Telix Pharmaceuticals Ltd SEC filings TLX
Telix Pharmaceuticals Ltd has 109 filings in SEC EDGAR's recent list, going back to Jan 25, 2024. Its latest annual report, Form 20-F, was filed on Feb 20, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 29, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 29, 2026 | Oct 29, 2026 |
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 21, 2026 | Sep 21, 2026 |
| 6-K | Current report (foreign issuer) | Sep 14, 2026 | Sep 14, 2026 |
| 6-K | Current report (foreign issuer) | Sep 2, 2026 | Sep 2, 2026 |
| 6-K | Current report (foreign issuer) | Sep 1, 2026 | Sep 1, 2026 |
| 6-K | Current report (foreign issuer) | Aug 20, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 21, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 2, 2026 | Jul 1, 2026 |
| 6-K | Current report (foreign issuer) | May 21, 2026 | May 20, 2025 |
| UPLOAD | Letter from the SEC | Apr 23, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 23, 2026 | Apr 22, 2026 |
| 6-K | Current report (foreign issuer) | Apr 21, 2026 | Apr 20, 2026 |
| 6-K | Current report (foreign issuer) | Apr 20, 2026 | Apr 19, 2026 |
| CORRESP | Letter to the SEC | Apr 17, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 14, 2026 | Apr 14, 2026 |
| 6-K | Current report (foreign issuer) | Apr 14, 2026 | Apr 14, 2026 |
| 6-K | Current report (foreign issuer) | Apr 13, 2026 | Apr 12, 2026 |
| 6-K | Current report (foreign issuer) | Apr 10, 2026 | Apr 9, 2026 |
| 6-K | Current report (foreign issuer) | Apr 9, 2026 | Apr 9, 2026 |
| 6-K | Current report (foreign issuer) | Apr 7, 2026 | Mar 31, 2026 |
| UPLOAD | Letter from the SEC | Apr 3, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 2, 2026 | Apr 1, 2026 |
| 20-F/A | Amended annual report (foreign issuer) | Mar 20, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 16, 2026 | Mar 15, 2026 |
| 6-K | Current report (foreign issuer) | Mar 10, 2026 | Mar 9, 2026 |
| F-3ASR | Filing | Feb 20, 2026 | — |
| 20-F | Annual report (foreign issuer) | Feb 20, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Feb 19, 2026 | Feb 17, 2026 |
| 6-K | Current report (foreign issuer) | Feb 18, 2026 | Feb 17, 2026 |
| 6-K | Current report (foreign issuer) | Feb 3, 2026 | Feb 2, 2026 |
| 6-K | Current report (foreign issuer) | Jan 20, 2026 | Jan 19, 2026 |
| 6-K | Current report (foreign issuer) | Jan 12, 2026 | Jan 12, 2026 |
| 6-K | Current report (foreign issuer) | Dec 22, 2025 | Dec 21, 2025 |
| 6-K | Current report (foreign issuer) | Dec 17, 2025 | Dec 17, 2025 |
| 6-K | Current report (foreign issuer) | Dec 8, 2025 | Dec 7, 2025 |
| 6-K | Current report (foreign issuer) | Oct 14, 2025 | Oct 14, 2025 |
| 6-K | Current report (foreign issuer) | Sep 23, 2025 | Sep 22, 2025 |
| 6-K | Current report (foreign issuer) | Sep 9, 2025 | Sep 8, 2025 |
| 6-K | Current report (foreign issuer) | Aug 28, 2025 | Aug 4, 2025 |
| 6-K | Current report (foreign issuer) | Aug 21, 2025 | Aug 20, 2025 |
| 6-K | Current report (foreign issuer) | Jul 22, 2025 | Jul 22, 2025 |
| 6-K | Current report (foreign issuer) | Jul 9, 2025 | Jul 8, 2025 |
| 6-K | Current report (foreign issuer) | Jun 11, 2025 | Jun 11, 2025 |
| 6-K | Current report (foreign issuer) | May 21, 2025 | May 20, 2025 |
| 6-K | Current report (foreign issuer) | Apr 29, 2025 | Apr 27, 2025 |
| 6-K | Current report (foreign issuer) | Apr 22, 2025 | Apr 22, 2025 |
| 6-K | Current report (foreign issuer) | Apr 17, 2025 | Apr 16, 2025 |
| 6-K | Current report (foreign issuer) | Apr 17, 2025 | Apr 15, 2025 |
| 6-K | Current report (foreign issuer) | Apr 8, 2025 | Apr 6, 2025 |
| 6-K | Current report (foreign issuer) | Apr 4, 2025 | Apr 3, 2025 |
| 6-K | Current report (foreign issuer) | Mar 21, 2025 | Mar 20, 2025 |
| 6-K | Current report (foreign issuer) | Mar 18, 2025 | Mar 17, 2025 |
| 6-K | Current report (foreign issuer) | Mar 12, 2025 | Mar 11, 2025 |
| 6-K | Current report (foreign issuer) | Feb 27, 2025 | Feb 25, 2025 |
| 6-K | Current report (foreign issuer) | Feb 26, 2025 | Feb 25, 2025 |
| 6-K | Current report (foreign issuer) | Feb 25, 2025 | Feb 25, 2025 |
| 6-K | Current report (foreign issuer) | Feb 24, 2025 | Feb 24, 2025 |
| 20-F | Annual report (foreign issuer) | Feb 24, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Feb 21, 2025 | Feb 20, 2025 |
| 6-K | Current report (foreign issuer) | Feb 13, 2025 | Feb 12, 2025 |
| 6-K | Current report (foreign issuer) | Jan 31, 2025 | Jan 30, 2025 |
| 6-K | Current report (foreign issuer) | Jan 27, 2025 | Jan 27, 2025 |
| 6-K | Current report (foreign issuer) | Jan 17, 2025 | Jan 16, 2025 |
| 6-K | Current report (foreign issuer) | Jan 13, 2025 | Jan 13, 2025 |
| 6-K | Current report (foreign issuer) | Jan 13, 2025 | Jan 12, 2025 |
| 6-K | Current report (foreign issuer) | Dec 30, 2024 | Dec 29, 2024 |
| S-8 | Employee stock plan registration | Dec 19, 2024 | — |
| SEC STAFF LETTER | Filing | Nov 21, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 19, 2024 | Nov 19, 2024 |
| 6-K | Current report (foreign issuer) | Nov 14, 2024 | Nov 12, 2024 |
| EFFECT | Filing | Nov 12, 2024 | — |
| SEC STAFF ACTION | Filing | Nov 12, 2024 | — |
| CERT | Filing | Nov 12, 2024 | — |
| CORRESP | Letter to the SEC | Nov 12, 2024 | — |
| 20FR12B/A | Filing | Oct 30, 2024 | — |
| SEC STAFF LETTER | Filing | Oct 28, 2024 | — |
| F-6 | Filing | Oct 17, 2024 | — |
| CORRESP | Letter to the SEC | Oct 17, 2024 | — |
| 20FR12B | Filing | Oct 17, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 10, 2024 | — |
| DRS | Filing | Sep 13, 2024 | — |
| RW | Filing | Jun 14, 2024 | — |
| RW | Filing | Jun 14, 2024 | — |
| 8-A12B | Filing | Jun 10, 2024 | — |
| F-1/A | Filing | Jun 5, 2024 | — |
| F-6 | Filing | May 30, 2024 | — |
| F-1 | Registration statement (foreign issuer) | May 17, 2024 | — |
| DRS/A | Filing | May 9, 2024 | — |
| DRS/A | Filing | Apr 15, 2024 | — |
| DRS/A | Filing | Mar 15, 2024 | — |
| DRS/A | Filing | Feb 2, 2024 | — |
| DRS | Filing | Jan 25, 2024 | — |
Showing 94 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TLX (Nasdaq), TLPPF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Australia
- Headquarters
- North Melbourne, Australia
- SEC filer status
- Large accelerated filer
- SEC CIK
- 2007191
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.